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MaOBJECTIVES This study assessed grayscale intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS)
detection of a histological ﬁbroatheroma (FA).
BACKGROUND NIRS-detected, lipid-rich plaques (LRPs) and IVUS-detected attenuated plaques are considered to
be vulnerable.
METHODS IVUS-attenuated plaque and NIRS-LRP (yellow or tan block chemogram) were compared with
histopathology in 1,943 sections of 103 coronary arteries from 56 autopsied hearts.
RESULTS IVUS-superﬁcial attenuation and NIRS-LRP showed a similar high speciﬁcity of approximately 95%, whereas
IVUS-superﬁcial attenuation alone had a poor sensitivity (vs. NIRS-LRP) in detecting FAs (36% vs. 47%; p ¼ 0.001).
Compared with FA sections with superﬁcial attenuation, FA sections without superﬁcial attenuation had a smaller plaque
burden (57.1% vs. 67.7%), a larger arc of calcium (79.7 vs. 16.8), and a lower prevalence of a $20% histological
necrotic core (28% vs. 50%) or late FA (14% vs. 37%; all p < 0.05). Compared with FA sections with NIRS-LRP, FA
sections without NIRS-LRP showed a smaller plaque burden (58.0% vs. 63.3%) and a lower prevalence of a $20%
necrotic core (27% vs. 46%). Conversely, non-FAs with NIRS-LRP (vs. non-FAs without LRP) showed a larger plaque
burden (55.1% vs. 46.3%), a greater prevalence of a$20% histological lipid pool (34% vs. 5%), and mostly pathological
intimal thickening (50%) or ﬁbrocalciﬁc plaque (33%). When sections showed either IVUS attenuation or NIRS-LRP, the
sensitivity for predicting a FA was signiﬁcantly higher compared with IVUS attenuation alone (63% vs. 36%; p < 0.001)
or NIRS-LRP alone (63% vs. 47%; p < 0.001). When sections showed both IVUS attenuation and NIRS-LRP, the positive
predictive value improved compared with IVUS attenuation alone (84% vs. 66%; p < 0.001) or NIRS-LRP alone (84% vs.
65%; p < 0.001).
CONCLUSIONS NIRS-LRP was more accurate than IVUS for predicting plaque containing a necrotic core or a large lipid
pool, and the combination was more accurate than either alone. (J Am Coll Cardiol Img 2015;8:184–94) © 2015 by the
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AB BR E V I A T I O N S
AND ACRONYM S
FA = ﬁbroatheroma
IQR = interquartile range
IVUS = intravascular
ultrasound
LCBI = lipid core burden index
LRP = lipid-rich plaque
MLA = minimal lumen area
NIRS = near-infrared
spectroscopy
PIT = pathological intimal
thickening
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185A utopsy studies have demonstrated that sud-den cardiac death and myocardial infarctionare mostly caused by rupture of a pre-
existing necrotic core and/or lipid core–rich ﬁbroa-
theroma (FA) (1–4). Similarly, in patients who have
undergone percutaneous coronary intervention, un-
stable plaques detected by in vivo intravascular imag-
ing modalities, including intravascular ultrasound
(IVUS)-attenuated plaques, were frequently associ-
ated with distal embolization and post-stenting
cardiac enzyme elevation (5–8). Intracoronary near-
infrared spectroscopy (NIRS) has been validated to
identify lipidic plaque (9–14). Extensive lipid-rich pla-
que (LRP) detected by NIRS was not only typical of
culprit lesions in ST-segment elevation myocardial
infarction, but it also predicted a high risk of peri-
procedural myocardial infarction. Recently, IVUS
and NIRS were combined in a single catheter so that
the 2 modalities could be acquired simultaneously
(14,15). The aims of this histopathological validation
study were to: 1) determine the accuracy of the gray-
scale IVUS and/or NIRS detection of a histological FA;
2) to clarify determinants of a false positive and a
false negative IVUS or NIRS study; and 3) to deter-
mine the incremental beneﬁt of the use of combined
NIRS and grayscale IVUS.SEE PAGE 195METHODS
SUBJECTS. Human coronary specimens were ob-
tained over a 2-year period from 62 autopsied patients
(10). As approved by the Institutional Review Board,
hearts were acquired from the National Disease
Research Interchange (Philadelphia, Pennsylvania) or
the International Institute for the Advancement of
Medicine (Edison, New Jersey), which also provided
information regarding age, sex, medical history, and
cause of death. The following terms were designated
as a cardiac cause of death: “myocardial infarction,”
“cardiac arrest,” and “other cardiac cause.”
Hearts were received within 48 h after death,
maintained on ice at 4C, and imaged within 96 h
after death. Major coronary arteries were harvested
for examination following in situ angioscopic
screening to exclude occluded segments that were
impassable by IVUS or NIRS catheters. Side branches
were ligated to prevent blood loss during perfusion,
and adventitial fat was kept intact. Each arterial
segment was mounted in a unique custom ﬁxture
with vertical guideposts at 2-mm intervals as refer-
ence points when comparing imaging with histologi-
cal studies. Both ends of the segment were attachedto luer connectors that allowed ﬂuid ﬂow and
catheter entry. A varistaltic pump (Manostat,
Barnant Company, Barrington, Illinois) sup-
plied pulsatile ﬂow at 60 cycles/min, and a
ﬂow rate of approximately 130 ml/min with
pressure maintained the physiological levels
(80 to 120 mm Hg).
Exclusion criteria were vessels in which
IVUS and NIRS images and histological sec-
tions could not be precisely matched, mini-
mum plaque, and poor image quality. After
excluding 2-mm-long sections with maximal
plaque thickness of <0.3 mm, a total of 1,943
2-mm long sections from 103 vessels from 56
autopsied hearts were included in the ﬁnal analysis.
IVUS IMAGE ACQUISITION AND ANALYSIS. An Atlantis
SR Pro 40-MHz catheter attached to an iLab system
(both Boston Scientiﬁc, Fremont, California) was
advanced over a 0.014-inch guidewire through the
coronary artery that was mounted in the ﬁxture. IVUS
imaging was performed using motorized pullback at
0.5 mm/s to include proximal and distal luer connec-
tors. Image data were archived onto a CD-ROM and
sent to an independent IVUS core laboratory (Cardio-
vascular Research Foundation, New York, New York)
for off-line analyses. Finally, every IVUS frame was
matched to its comparable histopathological slice
by using vessel shape, side branches, perivascular
structures, and distances from the luer connectors.
Grayscale IVUS analyses were performed using
validated planimetry software (echoPlaque, INDEC
Medical Systems, Santa Clara, California). Qualitative
and quantitative measurements were performed ac-
cording to the criteria of the American College of
Cardiology consensus statement on IVUS (16). Calci-
ﬁcation was brighter than the reference adventitia
with acoustic shadowing, with or without re-
verberations. The arc of calcium was measured; the
interobserver variability was 4.1  1.9. Superﬁcial
attenuated plaque was ultrasonic attenuation of
deeper arterial structures that began closer to the
lumen than to the adventitia despite the absence of
calcium (6,8,9). Plaques with deep attenuation (i.e.,
leading edge of attenuation closer to the adventitia
than to the lumen) (8) were not classiﬁed as attenu-
ated plaque in this study. The arc of attenuation was
measured in degrees and included only the attenu-
ated region without calciﬁcation; the interobserver
variability of the arc of the attenuation measurement
was 4.3  2.1. If there was >1 arc of attenuation in a
given image slice, the arcs were added.
All grayscale IVUS determinations were based on
the observations of 2 independent experienced
reviewers (S.K. and A.M.) who were blinded to
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186other data. Interobserver and intraobserver vari-
ability yielded good concordance for the diagnosis
of attenuated plaque (k ¼ 0.93 and k ¼ 0.97,
respectively).
NIRS IMAGE ACQUISITION AND ANALYSIS. Using
the same protocol for IVUS imaging, a 3.2-Fr InfraR-
eDx (Burlington, Massachusetts) NIRS catheter was
advanced into the distal coronary vessel. Automated
mechanical pullback was performed at a speed of
0.5 mm/s and 240 rpm. Catheter imaging included the
luer ﬁttings so that the catheter position within the
custom ﬁxture could be precisely known and regis-
tered with histology and IVUS. Raw spectra were ac-
quired at a rate of 40 Hz (1 spectrum every 25 ms).
Following the pullback, the probability of lipid core
plaque was displayed as a “chemogram,” which is a
digital color-coded map of the location and intensity
of lipid viewed from the luminal surface; the X-axis
indicated the pullback position in millimeters (pixels
every 0.1 mm), and the Y-axis indicated the circum-
ferential position in degrees (pixels every 1) as if the
vessel had been split open along its longitudinal axis
(10). The chemogram algorithm processed the spec-
troscopic information into a probability of lipid core
plaque and mapped it to a 128 (7-bit) red-to-yellow
color scale, with the lowest probability of lipid
shown as red and the highest probability shown as
yellow. Yellow pixels (pixels above the threshold for
the detection of lipidic plaque) were divided by all
viable pixels in the chemogram to generate the lipid
core burden index (LCBI) per mille (&). The NIRS
“block chemogram” is a summary metric that dis-
played the top 10th percentile probability for all
measurements of the corresponding 2-mm-long che-
mogram section binned to 4 discreet colors: red (p <
0.57), orange (0.57 # p <0.84), tan (0.84 # p <0.98),
and yellow (0.98 # p). The presence of a yellow or tan
block deﬁned LRP. NIRS image analyses were per-
formed off-line using an in-house, Matlab-based
software programmed at the Cardiovascular Research
Foundation.
HISTOPATHOLOGY ANALYSIS AND DEFINITIONS. After
the IVUS and NIRS images were obtained, segments
were pressure-ﬁxed in formalin and decalciﬁed with
ethylenediaminetetraacetic acid and sectioned into
2-mm-long blocks using the ﬁxture’s guideposts to
correspond to the 2-mm-long IVUS and NIRS sections.
Preparation of thin sections, staining, and histological
analysis were performed at the CVPath Institute
(Gaithersburg, Maryland). Histopathology slides of
5-mm thickness were prepared from the distal side of
each 2-mm-long block and stained with hematoxylin-
eosin and Russell-Movat’s pentachrome as previouslydescribed (10). With Movat’s pentachrome, elastic
ﬁbers stain black, collagen ﬁbers stain yellow, pro-
teoglycan stains green, and smooth muscle cells stain
red. Histological features of the arteries were classi-
ﬁed using a modiﬁed American Heart Association
plaque classiﬁcation method based on the agreement
of 2 CVPath Institute pathologists (A.P.B. and R.V.)
who were blinded to the IVUS and NIRS ﬁndings
(3,4). Morphometric and/or quantitative assessment
of the arc and size of the necrotic core, lipid pool,
and calciﬁcation was determined by an automatic
computer-assisted technique as previously described
(10). The necrotic core and lipid pool were quantiﬁed
as <10%, 10% to 20%, 20% to 40%, and >40% of
the total plaque area. A histological FA included: 1)
an early FA with an early necrotic core characterized
by small cholesterol clefts and cellular debris with
structured matrix; 2) a late FA with a late necrotic
core characterized by increased cellular debris and
cholesterol clefts, but with complete degradation of
the extracellular structured matrix; and 3) a thin-
cap FA with a large late necrotic core covered by a
thin ﬁbrous cap (<65 mm) (3,4,8). A focal FA was
a FA that was conﬁned within only 1 2-mm-long
section. At least 2 non-FA sections separated indi-
vidual FAs.
This database was collected for the development of
the algorithm for infrared spectroscopy (10), and the
sample size was based on this purpose. Gardner et al.
(10) used 86 human coronary artery segments from 33
hearts and then tested 126 coronary segments from 51
hearts in a prospective study. We used the same
database after excluding some cases that had non-
qualiﬁed IVUS images or normal segments (maximum
intimal thickness <0.3 mm).
STATISTICAL ANALYSIS. Data analyses were per-
formed using SPSS version 12.0 (IBM Corporation,
Armonk, New York) or SAS version 9.1 (SAS Institute
Inc., Cary, North Carolina). Categorical data were
expressed as absolute values and percentages and
compared using chi-square statistics or Fisher’s
exact test. Continuous data were reported as median
(interquartile range [IQR]) and compared using
nonparametric Mann-Whitney tests. For section-level
data, a model with a generalized estimating equation
approach was used to compensate for potential clus-
ter effects of multiple sections in the same patient
and presented as least-square means with 95% con-
ﬁdence intervals. Interobserver and intraobserver
variability were assessed by k statistical analysis that
corrected for the chance of simple agreement and
accounted for systematic observer bias; a k > 0.80
indicated good agreement, and a k between 0.61 and
0.80 indicated moderate agreement. The p values
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187were adjusted with the generalized estimating equa-
tion method for repeated measures. Inferential sta-
tistical tests were conducted at the signiﬁcance level
of 0.05.
RESULTS
BASELINE PATIENT AND LESION CHARACTERISTICS.
Median patient age was 63.0 years (IQR: 50.3 to
77.8 years); and 37 of the patients (66%) were men.
Twenty-ﬁve (45%) patients died from cardiac causes
(12 cardiac arrests, 6 myocardial infarctions, and
7 deaths from other cardiac causes), and 19 (34%)
patients died from a cerebrovascular accident. Hy-
pertension, diabetes mellitus, and smoking were
documented in 32 (57%), 17 (30%), and 27 (48%)
patients, respectively.
A total of 1,943 2-mm-long histological sections
were analyzed. Figure 1 shows IVUS plaque atten-
uation, NIRS-LCBI, and NIRS-block chemogramFIGURE 1 IVUS and NIRS Findings According to Plaque Classiﬁcation
Frequency of IVUS attenuation (top panel), lipid core burden index (LCB
(bottom panel). AIT ¼ adaptive intimal thickening; FA ¼ ﬁbroatheroma;
PIT ¼ pathological intimal thickening; SMC ¼ smooth muscle cell.analysis according to the pre-speciﬁed histological
classiﬁcation.
PREDICTION OF FIBROATHEROMA BY SECTION-LEVEL
IVUS ANALYSIS. Only 67 of 1,577 2-mm-long, non-
FA–containing sections showed superﬁcial grayscale
IVUS attenuation (false positive: 4%), whereas
234 (64%) of 366 2-mm-long FA-containing sections
had no superﬁcial grayscale IVUS attenuation
(false negative: 64%) (Table 1). Compared with FA-
containing sections with superﬁcial attenuation,
FA-containing sections without superﬁcial attenua-
tion had a larger lumen, a smaller plaque burden, a
larger arc of calcium on IVUS (Table 1), and a smaller
necrotic core on histology (Figure 2). Moreover,
histological FAs with superﬁcial grayscale IVUS
attenuation were more often classiﬁed as a late FA
versus histological FAs without superﬁcial attenua-
tion (37% vs. 14%; p < 0.001). Of the 81 of 136 (60%)
FA-containing segments with no superﬁcial IVUSI) (middle panel), and frequency of NIRS block chemogram
IVUS ¼ intravascular ultrasound; NIRS ¼ near-infrared spectroscopy;
Kang et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 2 , 2 0 1 5
IVUS and NIRS in Fibroatheromas F E B R U A R Y 2 0 1 5 : 1 8 4 – 9 4
188attenuation, 46 (57%) were focal and conﬁned
within only 1 2-mm-long histological section.
Finally, of the 677 sections with any amount of
IVUS-detected calciﬁcation, 232 (34%) contained
histological FAs.
Histological FAs with superﬁcial attenuation (vs.
histological FAs without superﬁcial attenuation) were
associated with smaller arcs of IVUS intraplaque cal-
cium (16.8 [0 to 44.1] vs. 79.7 [0 to 138.5]; p <
0.001). In sections containing histological FAs, an arc
of calcium cut-off value <35.5 separated attenuated
from nonattenuated plaque (area under the curve:
0.70, 95% conﬁdence interval [CI]: 0.642 to 0.748; p <
0.001). Similarly, histological FAs with superﬁcial
IVUS attenuation (vs. histological FAs without atten-
uation) were associated with greater plaque burden
(67.7% [95% CI: 58.1% to 72.8%] vs. 57.1% [95% CI:
50.4% to 63.5%]; p < 0.001). A plaque burden
of $62.3% separated attenuated from nonattenuated
plaque (area under the curve: 0.72, 95% conﬁdence
interval: 0.663 to 0.775; p < 0.001).TABLE 1 Morphologic Characteristics Between Sections With Versus
FA (n ¼ 366)
Attenuation
(n ¼ 132)
No Attenuation
(n ¼ 234)
Grayscale IVUS
Lumen, mm2 4.8 (3.3–7.0) 6.0 (4.5–7.5)
EEM, mm2 14.8 (12.4–20.3) 14.3 (11.4–17.9)
PþM, mm2 10.1 (7.6–13.4) 8.2 (6.1–10.7)
Plaque burden, % 67.7 (58.1–72.8) 57.1 (50.4–63.5)
Arc of calcium,  16.8 (0–44.1) 79.7 (0–138.5)
Calcium 71 (54%) 161 (69%)
NIRS-LCBI 259.3 (97.7–408.7) 144.3 (0–317.9)
NIRS block chemogram
Red 34 (29%) 101 (43%)
Orange 22 (17%) 36 (15%)
Tan 24 (18%) 38 (16%)
Yellow 52 (39%) 59 (25%)
Plaque type
AIT
SMC rich
Bland ﬁbrous
Intimal xanthoma
Fibrocalciﬁc
Calciﬁed nodule
PIT
Early FA 45 (34%) 78 (33%)
Early FA, calciﬁed 14 (11%) 48 (21%)
Late FA 49 (37%) 34 (14%)
Late FA, calciﬁed 17 (13%) 67 (29%)
Thin-cap FA 7 (5%) 7 (3%)
Values are generalized estimating equation least-square mean (95% conﬁdence interval
AIT ¼ adaptive intimal thickening; EEM ¼ external elastic membrane; FA ¼ ﬁbroather
infrared spectroscopy; PþM ¼ plaque plus media; PIT ¼ pathological intimal thickeningPREDICTION OF FIBROATHEROMA BY SECTION-LEVEL
NIRS ANALYSIS. As shown in Table 2, 193 of 366 FA-
containing sections had no LRP (no yellow or tan
NIRS block chemogram; false negative: 53%).
Compared with FA-containing sections with NIRS-
LRP, FA sections without NIRS-LRP were associated
with a smaller IVUS plaque burden, less IVUS atten-
uation, and a lower prevalence of $20% histological
necrotic core (27% vs. 46%) (Figure 2). However, there
was no signiﬁcant difference in the presence of cal-
cium or arc of calcium between FA sections with
versus without NIRS-LRP. In contrast, 92 of 1,577 non-
FA–containing sections showed NIRS-LRP (false pos-
itive: 6%); this appeared to be related to a greater
plaque burden and a larger external elastic membrane
size on IVUS. In non-FA sections with LRP (yellow or
tan NIRS block chemogram), the major histological
lesion types were pathological intimal thickening
(PIT) (50%) and ﬁbrocalciﬁc plaque (33%). A lipid
pool $20% was observed in 34% of non-FA sections
with NIRS-LRP, whereas only 5% of the non-FAWithout Intravascular Ultrasound Attenuation
Non-FA (n ¼ 1,577)
p Value
Attenuation
(n ¼ 67)
No Attenuation
(n ¼ 1,510) p Value
0.006 5.7 (3.9–7.3) 6.1 (4.4–8.2) 0.16
0.29 14.9 (11.5–19.1) 11.5 (8.5–15.5) 0.009
0.24 9.1 (7.2–12.0) 5.1 (3.2–8.0) <0.001
<0.001 61.4 (54.6–66.8) 46.4 (35.7–55.8) <0.001
<0.001 0 (0–35) 0 (0–20.5) 0.010
0.010 32 (48%) 413 (27%) 0.46
0.010 29.2 (0–171.9) 0 (0–23.5) <0.001
45 (67%) 1369 (91%)
0.005 7 (10%) 65 (4%) <0.001
6 (9%) 41 (3%)
9 (13%) 35 (2%)
7 (10%) 631 (42%)
2 (3%) 109 (7%)
7 (10%) 94 (6%) 0.001
0 (0%) 28 (2%)
17 (25%) 362 (24%)
1 (2%) 14 (1%)
33 (29%) 272 (18%)
<0.001
s) or n (%). Nonparametric (Mann-Whitney) test.
oma; IVUS ¼ intravascular ultrasound; LCBI ¼ lipid core burden index; NIRS ¼ near-
; SMC ¼ smooth muscle cell.
FIGURE 2 Comparison of Necrotic Core and Lipid Pool
(A) Necrotic core between FA with versus without IVUS attenuation. (B) Lipid pool between non-FA with versus without IVUS attenuation.
(C) Necrotic core between FA with versus without NIRS–lipid-rich plaque (LRP). (D) Lipid pool between non-FA with versus without NIRS-LRP.
Abbreviations as in Figure 1.
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189sections without NIRS-LRP showed a lipid pool $20%
(Figure 2). If, however, a yellow NIRS block chemo-
gram was used to predict a histological FA, the
sensitivity was 30%, the speciﬁcity was 97%, the
positive predictive value was 71%, and the negative
predictive value was 86%.
Overall, 61 of 136 FAs (45%) included no section
with NIRS-LRP. Of these 61 FAs, 38 (62%) were focal
and conﬁned within only 1 2-mm-long histological
section.
PREDICTION OF FIBERATHEROMA AT THE MINIMAL
LUMEN AREA SITE. Overall, 103 histological sections
from the minimal lumen area (MLA) site were
interpreted to show 20 sections with adaptive in-
timal thickening, 5 sections with smooth muscle
cell-rich plaque, 2 with bland ﬁbrous plaque, 16
with ﬁbrocalciﬁc plaque, 16 with PIT, 16 with early
FAs, 9 with calciﬁed early FAs, 7 with late FAs, 9
with calciﬁed late FAs, and 3 with thin-cap FAs.
Table 3 compares grayscale IVUS and NIRS ﬁndings
between 44 MLA sections with a FA versus 59 MLA
sections without a FA.In 44 MLA sections with a FA, 36 (82%) showed
NIRS-LRP, whereas superﬁcial attenuated plaque was
seen in only 19 (43%). In the 25 FA-containing MLA
sections without superﬁcial plaque attenuation, 16
(64%) showed IVUS calcium with a median arc of
130.4 (IQR: 71.8 to 163.9), and NIRS-LRP was
observed in 20 sections (80%). Conversely, in 59 MLA
sections without a FA, 58 (98%) had no attenuated
plaque, and 56 (95%) showed no NIRS-LRP.
COMPARISON OF IVUS AND NIRS AND THE COMBINATION.
Focal FAs were more frequently associated with both
false negative NIRS-LRP (70% vs. 28%; p < 0.001) and
false negative superﬁcial IVUS attenuation (85% vs.
43%; p < 0.001) compared with FAs that spanned >1
histological section. Of the 232 FA-containing sec-
tions with IVUS-detectable calcium, 128 (55%) showed
NIRS-LRP, whereas only 71 (30%) sections showed
grayscale IVUS attenuation that was distinct from the
shadowing caused by calciﬁcation. In the remaining
161 (70%) sections without attenuation, 65 (40%) had
LRP on the NIRS block chemogram. Figure 3 demon-
strates examples of a calciﬁed lesion with NIRS-LRP.
TABLE 2 Morphologic Characteristics Between Sections With Versus Without NIRS-LRP
FA (n ¼ 366) Non-FA (n ¼ 1,577)
LRP
(n ¼ 173)
No LRP
(n ¼ 193) p Value
LRP
(n ¼ 92)
No LRP
(n ¼ 1,485) p Value
Grayscale IVUS
Lumen, mm2 5.1 (3.8–7.3) 6.0 (4.3–7.6) 0.47 6.2 (4.4–8.4) 6.0 (4.4–8.1) 0.23
EEM, mm2 14.3 (11.9–18.0) 14.7 (11.5–18.5) 0.1 14.8 (9.8–18.3) 11.5 (8.5–15.4) <0.001
PþM, mm2 9.1 (7.1–11.7) 8.4 (6.2–1.1) <0.001 7.8 (4.9–11.2) 5.1 (3.2–8.1) <0.001
Plaque burden, % 63.3 (54.3–71.0) 58.0 (51.5–65.5) <0.001 55.1 (49.9–61.4) 46.3 (35.4–56.2) <0.001
Attenuation 76 (44%) 56 (29%) 0.003 15 (16%) 52 (3.5%) <0.001
Arc of calcium,  35.8 (0–107.9) 40.7 (0–117.9) 0.75 17.2 (0–130.0) 0 (0–20.3) 0.001
Calcium 128 (66%) 104 (60%) 0.44 48 (52.2%) 397 (26.7%) <0.001
Plaque type
AIT 6 (6.5%) 632 (42.5%)
SMC rich 5 (5.4%) 106 (7.1%)
Bland ﬁbrous 3 (3.3%) 98 (6.6%)
Intimal xanthoma 2 (2.2%) 26 (1.7%) <0.001
Fibrocalciﬁc 30 (32.6%) 349 (23.5%)
Calciﬁed nodule 0 (0%) 15 (1.0%)
PIT 46 (50.0%) 259 (17.4%)
Early FA 63 (36.4%) 60 (31.1%)
Early FA, calciﬁed 22 (12.7%) 40 (20.7%)
Late FA 47 (27.2%) 36 (18.7%) 0.068
Late FA, calciﬁed 34 (19.7%) 50 (25.9%)
Thin-cap FA 7 (4.0%) 7 (3.6%)
Values are generalized estimating equation least-square mean (95% conﬁdence interval) or n (%). Nonparametric (Mann-Whitney) test.
Abbreviations as in Table 1.
TABLE 3
Grayscale
Lumen,
EEM, m
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Plaque
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Arc of a
Arc of c
Calcium
NIRS-bloc
LRP (tan
2 mm-L
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190Accuracies of IVUS versus NIRS for the prediction
of FA were compared at the MLA sites (Figure 4, left
panel) and overall (Figure 4, middle panel). Table 4
summarizes factors affecting FA detection by IVUS or
NIRS. For the prediction of a histological FA, smaller
plaque burden, lesser amounts of necrotic core, and
focal FA resulted in higher rates of false negatives byLesion Characteristics at the Minimal Lumen Area Site
FA
(n ¼ 44)
Non-FA
(n ¼ 59) p Value
IVUS
mm2 4.0 (3.5–4.4) 4.4 (3.9–4.8) 0.25
m2 13.5 (12.3–14.7) 10.0 (9.0–11.0) <0.001
m2 9.4 (8.3–10.4) 5.7 (4.9–6.4) <0.001
burden, % 57.8 (64.6–70.9) 56.4 (52.5–60.3) <0.001
tion 19 (43%) 1 (2%) <0.001
ttenuation,  47.2 (24.9–70.5) 2.5 (-1.9–6.9) <0.001
alcium,  60.5 (38.4–82.6) 23.7 (9.9–37.6) 0.005
26 (59%) 19 (31%) 0.02
k chemogram
or yellow) 36 (82%) 3 (5%) <0.001
CBI 313.9 (262.6–365.2) 35.8 (12.2–59.5) <0.001
eneralized estimating equation least square mean (95% conﬁdence interval) or n (%).
tric (Mann-Whitney) test.
ions as in Table 1.both IVUS and NIRS. Calciﬁed plaques (that, by deﬁ-
nition, were classiﬁed as “no attenuation”) were also
more likely to increase the rate of false negative IVUS
assessment, whereas they rarely affected NIRS
assessment. Histological PIT with a large lipid pool
often had NIRS-LRP.
Among the 136 FA-containing histopathologic
segments, 34 (25%) showed both IVUS attenuation
and NIRS-LRP, whereas 86 (63%) showed either
IVUS attenuation or NIRS-LRP. Figure 4 (right panel)
shows the accuracies of combining IVUS and NIRS
assessment overall (Figure 4A) and at the MLA site
(Figure 4B). When sections showed either IVUS-
attenuation or NIRS-LRP, the sensitivity for pre-
dicting a FA was signiﬁcantly higher compared with
IVUS attenuation alone (63% vs. 36%; p < 0.001) or
NIRS-LRP alone (63% vs. 47%; p < 0.001). When
sections showed both IVUS attenuation and NIRS-
LRP, the positive predictive value improved
compared with IVUS attenuation alone (84% vs.
66%; p < 0.001) or NIRS-LRP alone (84% vs. 65%;
p < 0.001). When either IVUS attenuation or NIRS-
LRP was present at the MLA sites (n ¼ 103), the
sensitivity (89% vs. 43%; p < 0.001) and the nega-
tive predictive value (92% vs. 70%; p < 0.001) were
much better than IVUS attenuation alone. However,
FIGURE 3 An Example of Calciﬁed Plaque by Intravascular Ultrasound
(A) Extensive superﬁcial calciﬁcation. (B) At the corresponding site (arrow), near-infrared spectroscopy chemogram showed “yellow” lipid-rich
plaque. Histopathology slides demonstrated late ﬁbroatheroma with calciﬁed core. (C) Hematoxylin-eosin stain. (D) Russell-Movat pentach-
rome stain.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 2 , 2 0 1 5 Kang et al.
F E B R U A R Y 2 0 1 5 : 1 8 4 – 9 4 IVUS and NIRS in Fibroatheromas
191there were no signiﬁcant differences compared with
NIRS-LRP (all p > 0.05).
DISCUSSION
This study focused on the use of IVUS, NIRS, and/or
the combination for identifying unstable plaques,
speciﬁcally FAs. 1) Both IVUS attenuation and NIRS-
LRP showed a high speciﬁcity of 96% and 94%,
respectively, for predicting a histological FA.
Conversely, superﬁcial IVUS attenuation had a poor
sensitivity of 36% that was explained by greater
calciﬁcation (whose presence, by deﬁnition, pre-
cluded the “diagnosis” of attenuation), smaller pla-
que burden, and more focal and less advanced FA.
2) NIRS-LRP signiﬁcantly improved the sensitivity
for detecting a histological FA, especially in calciﬁedlesions and lesions with a smaller plaque burden. 3)
At the MLA site, the sensitivity, negative predictive
value, and overall accuracy of NIRS were much better
than that of IVUS. 4) When either IVUS attenuation or
NIRS-LRP was present, the sensitivity for predicting
FAs improved; when both IVUS-attenuation and
NIRS-LRP were present, the positive predictive value
also improved. However, this was less dramatic at
MLA sites where the combination of IVUS and NIRS
was superior to IVUS alone, but not to NIRS alone.
Attenuated plaque on grayscale IVUS indicates a
high risk for no-reﬂow or an elevation in post-
procedural creatine kinase-MB (5–7). Virtual histo-
logical IVUS and optical coherence tomography have
shown attenuated plaque to be a marker for a large
necrotic core and a thin-cap FA (5–7). Pu et al. (8)
reported that histological FAs were found in 97%
FIGURE 4 Comparison of Accuracies of IVUS-Attenuated Versus NIRS-LRP
(A to C) Comparison of accuracies of IVUS attenuation versus NIRS-LRP at the minimum lumen area (MLA) sites. (A) In 103 sections at the MLA site (FA in 43%). (B) In 33
sections with IVUS-detected calcium $35.5 (FA in 67%). (C) In 52 sections with plaque burden <62.3% (FA in 21%). *p < 0.05 versus IVUS attenuation. (D to F)
Comparison of accuracies of IVUS-attenuation versus NIRS-LRP. (D) The overall cohort of 1,943 sections (FA in 19%). (E) The cohort of 542 sections with IVUS-detected
calciﬁcation $35.5 (FA in 37%). (F) The cohort of 1,578 sections with plaque burden <62.3% (FA in 13%). *p < 0.05 versus IVUS attenuation. (G and H) Accuracies
of IVUS attenuation and/or NIRS-LRP for predicting FA in (G) all 1,943 sections or (H) in 103 sections at the MLA sites. Green bars indicate the presence of both
IVUS attenuation and NIRS-LRP, whereas blue bars indicate the presence of either IVUS attenuation or NIRS-LRP. †p < 0.05 versus IVUS attenuation; ‡p < 0.05 versus
NIRS-LRP. NPV ¼ negative predictive value; PPV ¼ positive predictive value; other abbreviations as in Figures 1 and 2.
TABLE 4 Factors Af
IVUS At
False positive (non-FA
with attenuation)
Larger lipid pool
LRP ¼ lipid-rich plaque; ot
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192of plaques with superﬁcial IVUS attenuation, 31% of
plaques with deep IVUS attenuation, and 27% of
plaques without IVUS attenuation. Because the posi-
tive predictive value of deep attenuation was as poor
as “no attenuation,” the present analysis did not
include deep attenuation and only reported superﬁ-
cial attenuation.
By deﬁnition, attenuated plaque excludes “atten-
uation (or, more correctly, shadowing) behind cal-
cium.” In the present study, 52% of plaques with
IVUS-detected calcium were FAs. Although FAs were
commonly associated with calciﬁcation, calciﬁedfecting Detection of a FA by IVUS or NIRS
tenuation NIRS-LRP
False negative (FA
without attenuation)
False positive
(non-FA with LRP)
False negative
(FA without LRP)
Calciﬁcation focal
FA (#2 mm)
Larger lumen
Smaller plaque burden
Less necrotic core
earlier stage of FA
PIT
Fibrocalciﬁc plaque
Larger lipid pool
Larger plaque burden
Focal FA (#2 mm)
Smaller plaque
burden
Less necrotic core
her abbreviations as in Table 1.lesions represented a major blind spot for IVUS. In the
present analysis, the sensitivity of IVUS attenuation
for detecting a histological FA was not >30% in both
calciﬁed lesions and lesions with a smaller plaque
burden. When there is more calcium, diagnoses of
FAs are less reliable by IVUS. In histological FAs, an
arc of intraplaque calcium $35.5 and a plaque
burden <62.3% best separated “no IVUS attenua-
tion” from attenuation. Among FA-containing his-
tological sections, 55% had an arc of calcium $35.5
and 57% a plaque burden <62.3%; thus, more than
one-half of the FAs were at risk for being mis-
diagnosed. (However, when plaques with shadowing
caused by calciﬁcation were added to the cohort of
attenuated plaques in the absence of calcium, the
sensitivity for prediction of an FA increased to 80%,
but the speciﬁcity decreased to 69%, with a false
positive rate of 30%.) Similar to previous data using
NIRS and virtual histological IVUS (13), our study
clearly demonstrated that calcium rarely affected the
sensitivity of the NIRS block chemogram.
At MLA sites, NIRS-LRP showed signiﬁcantly
higher sensitivity (82% vs. 43%), negative predictive
value (88% vs. 70%), and overall accuracy (89% vs.
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19375%) versus IVUS attenuation. The beneﬁt of NIRS
assessment was remarkable, especially in MLA sec-
tions that contained more calcium and a smaller
plaque burden. Although a smaller plaque burden
was associated with false negative ﬁndings by both
IVUS (FAs without attenuation) and NIRS (FAs
without LRP), it was less likely to affect NIRS
compared with IVUS. However, assessment of unsta-
ble lesion morphology cannot be conﬁned to only the
MLA site or the region with the largest plaque.
Although the NIRS block chemogram enhanced the
sensitivity for FA detection relative to IVUS, it still
had false positives or false negatives. First, histolog-
ical FAs without NIRS-LRP (false negatives) were
characterized by a smaller plaque burden with a
lesser necrotic core, which suggested less advanced
atherosclerotic disease. More importantly, 62% of
histological FA segments without NIRS-LRP showed
a focal FA. Conversely, the present data clearly
demonstrated the high sensitivity (82%) and speci-
ﬁcity (95%) of NIRS-LRP for detecting a histological
FA at the MLA site where the atherosclerotic lesion
looked the most signiﬁcant. Second, non-FAs with
NIRS-LRP (false positive) were mostly PIT (50%) with
a large lipid pool. Because the NIRS signal is gener-
ated by lipid, such false positive results may indicate
a stage of pathology preceding an FA. Moreover, 33%
of non-FAs with NIRS-LRP were ﬁbrocalciﬁc plaques
(plaques with a necrotic core completely surrounded
by calcium that were classiﬁed as ﬁbrocalciﬁc), and
NIRS may have been sensitive to the remnant necrotic
core within the calcium. Despite no direct inﬂuence of
calcium on the result of the NIRS block chemogram, a
false positive NIRS-LRP was more likely associated
with calciﬁcation, which may be partly explained by
the high incidence of ﬁbrocalciﬁc plaque.
The ﬁndings demonstrate the complementary use
of both sound (IVUS) and light (NIRS) to characterize
plaques. IVUS is excellent for assessing structures and
of calciﬁcation, whereas NIRS is a chemical method
well-suited to the detection of lipid; the 2 are now
available in a single catheter as the ﬁrst combined
intravascular imaging device. This present study
demonstrated that combining IVUS and NIRSovercame some of the limitations of each technique
and was more accurate than either IVUS or NIRS
alone. For example, the use of superﬁcial attenuation
as the IVUS sign of an FA is frequently precluded by
the presence of calciﬁcation; NIRS can detect lipid
despite extensive calciﬁcation.
STUDY LIMITATIONS. Because this autopsy-based
study evaluated hearts from 2 research tissue pro-
curers, the results cannot be extended to the general
population. Second, standard histological preparation
requires dehydration of the tissue specimen before
the tissue is embedded; this dissolves and elutes
lipid, leaving an empty vacuole as presumptive evi-
dence of previous lipid accumulation. Third, imaging
was performed within 48 h post-mortem, and the
specimen degradation tissue changes were not eval-
uated, which is a fundamental limitation of all au-
topsy studies. Fourth, despite our efforts to verify the
correct matching among IVUS, NIRS, and histological
sections, there might be inherent discordances that
inﬂuenced accuracies. Because the purpose of this
study was to determine the accuracy of the grayscale
IVUS and/or NIRS detection of histological FAs,
assessment of plaque rupture or thrombi was not
considered in the present analysis. However, the
impact of the present ﬁndings on clinical outcomes
needs to be studied.
CONCLUSIONS
For the prediction of a plaque-containing necrotic
core or large lipid pool, NIRS assessment improved
the sensitivity and diagnostic accuracy compared
with IVUS, especially in calciﬁed plaque and lesions
with small plaque burden. However, the combination
of NIRS and IVUS, which is now possible in a single
multimodality imaging catheter, was superior
compared with NIRS or IVUS alone.
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